Literature DB >> 26989187

Release the hounds: virotherapy with immunotherapy.

Tapan M Kadia1.   

Abstract

In this issue of Blood, Shen et al demonstrate that the vesicular stomatitis virus (VSV)-murine interferon β (IFNβ)-sodium iodide symporter (NIS) (VSV-mIFNβ-NIS) oncolytic virus has significant antileukemia activity, which is enhanced when combined with an anti-programmed death-ligand 1 (PD-L1) antibody.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26989187      PMCID： PMC4797017          DOI： 10.1182/blood-2016-01-690891

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  How I treat refractory and early relapsed acute myeloid leukemia.

Authors:  Felicitas Thol; Richard F Schlenk; Michael Heuser; Arnold Ganser
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

2.  Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.

Authors:  Weiwei Shen; Mrinal M Patnaik; Autumn Ruiz; Stephen J Russell; Kah-Whye Peng
Journal:  Blood       Date:  2015-12-28       Impact factor: 22.113

3.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Authors:  Robert H I Andtbacka; Howard L Kaufman; Frances Collichio; Thomas Amatruda; Neil Senzer; Jason Chesney; Keith A Delman; Lynn E Spitler; Igor Puzanov; Sanjiv S Agarwala; Mohammed Milhem; Lee Cranmer; Brendan Curti; Karl Lewis; Merrick Ross; Troy Guthrie; Gerald P Linette; Gregory A Daniels; Kevin Harrington; Mark R Middleton; Wilson H Miller; Jonathan S Zager; Yining Ye; Bin Yao; Ai Li; Susan Doleman; Ari VanderWalde; Jennifer Gansert; Robert S Coffin
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

Review 4.  Immune Checkpoint Blockade in Cancer Therapy.

Authors:  Michael A Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

Review 5.  Neoantigens in cancer immunotherapy.

Authors:  Ton N Schumacher; Robert D Schreiber
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

6.  Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.

Authors:  S Naik; R Nace; G N Barber; S J Russell
Journal:  Cancer Gene Ther       Date:  2012-04-20       Impact factor: 5.987

Review 7.  Oncolytic virotherapy.

Authors:  Stephen J Russell; Kah-Whye Peng; John C Bell
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908
  7 in total
  2 in total

1.  Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death.

Authors:  Geetanjali Lal; Maitreyi S Rajala
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

Review 2.  Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs.

Authors:  Vanessa Innao; Vincenzo Rizzo; Andrea Gaetano Allegra; Caterina Musolino; Alessandro Allegra
Journal:  Curr Oncol       Date:  2020-12-25       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.